University Micrdrilms International 300 N

Total Page:16

File Type:pdf, Size:1020Kb

University Micrdrilms International 300 N A COMPARISON OF THE EFFECTIVENESS OF SEVERAL THIOLIC CHELATING AGENTS ON THE MOBILIZATION OF ARSENIC IN THE RABBIT. Item Type text; Thesis-Reproduction (electronic) Authors Hoover, Todd David. Publisher The University of Arizona. Rights Copyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author. Download date 24/09/2021 12:49:10 Link to Item http://hdl.handle.net/10150/274892 INFORMATION TO USERS This reproduction was made from a copy of a document sent to us for microfilming. While the most advanced technology has been used to photograph and reproduce this document, the quality of the reproduction is heavily dependent upon the quality of the material submitted. The following explanation of techniques is provided to help clarify markings or notations which may appear on this reproduction. 1.The sign or "target" for pages apparently lacking from the document photographed is "Missing Page(s)". If it was possible to obtain the missing page(s) or section, they are spliced into the film along with adjacent pages. This may have necessitated cutting through an image and duplicating adjacent pages to assure complete continuity. 2. When an image on the film is obliterated with a round black mark, it is an indication of either blurred copy because of movement during exposure, duplicate copy, or copyrighted materials that should not have been filmed. For blurred pages, a good image of the page can be found in the adjacent frame. If copyrighted materials were deleted, a target note will appear listing the pages in the adjacent frame. 3. When a map, drawing or chart, etc., is part of the material being photographed, a definite method of "sectioning" the material has been followed. It is customary to begin filming at the upper left hand corner of a large sheet and to continue from left to right in equal sections with small overlaps. If necessary, sectioning is continued again—beginning below the first row and continuing on until complete. 4. For illustrations that cannot be satisfactorily reproduced by xerographic means, photographic prints can be purchased at additional cost and inserted into your xerographic copy. These prints are available upon request from the Dissertations Customer Services Department. 5. Some pages in any document may have indistinct print. In all cases the best available copy has been filmed. University Micrdrilms International 300 N. Zeeb Road Ann Arbor, Ml 48106 1321805 HOCVER, TODD DAVID A COMPARISON OF THE EFFECTIVENESS OF SEVERAL THIOLIC CHELATING AGENTS ON THE MOBILIZATION OF ARSENIC IN THE RABBIT THE UNIVERSITY OF ARIZONA M.S. 1983 University Microfilms International 300 N. Zeeb Road, Ann Arbor, MI 48106 PLEASE NOTE: In all cases this material has been filmed in the best possible way from the available copy. Problems encountered with this document have been identified here with a check mark V . 1. Glossy photographs or pages 2. Colored illustrations, paper or print 3. Photographs with dark background 4. Illustrations are poor copy 5. Pages with black marks, not original copy 6. Print shows through as there is text on both sides of page 7. Indistinct, broken or small print on several pages ^ 8. Print exceeds margin requirements 9. Tightly bound copy with print lost in spine 10. Computer printout pages with indistinct print 11. Page(s) lacking when material received, and not available from school or author. 12. Page(s) seem to be missing in numbering only as text follows. 13. Two pages numbered . Text follows. 14. Curling and wrinkled pages 15. Other _____ University Microfilms International A COMPARISON OF THE EFFECTIVENESS OF SEVERAL THIOLIC CHELATING AGENTS ON THE MOBILIZATION OF ARSENIC IN THE RABBIT by Todd David Hoover A Thesis Submitted to the Faculty of the COMMITTEE ON TOXICOLOGY In Partial Fulfillment of the Requirements For the Degree of MASTER OF SCIENCE WITH A MAJOR IN TOXICOLOGY In the Graduate College THE UNIVERSITY OF ARIZONA 19 8 3 STATEMENT BY AUTHOR This thesis has been submitted in partial fulfillment of requirements for an advanced degree at The University of Arizona and is deposited in the University Library to be made available to borrowers under rules of the Library. Brief quotations from this thesis are allowable without special permission, provided that accurate acknowledgment of source is made. Requests for permission for extended quotation from or reproduction of this manuscript in whole or in part may be granted by the head of the major department or the Dean of the Graduate College when in his judgment the proposed use of the material is in the interests of scholarship. In all other instances, however, permission must be obtained from the author. SIGNED: JO". APPROVAL BY THESIS DIRECTOR This thesis has been approved on the date shown below: /s/Y- a*.* i& i ft* H.1V. Aposhian A Date Professor of Pharmacoloy and of Cellular and Developmental Biology ACKNOWLEDGMENTS I would like to express my appreciation to the members of 1117 conmittee for their time and helpful suggestions during the course of this work. In particular I wish to thank Dr. Vasken Aposhian for his efforts in directing this research and for his continued optimism and support which have made my association with him an enjoyable experience. I also wish to thank my parents for making my first step down the long road of higher education possible. Most of all I wish to thank my wife, Laney, for her love and constant encouragement and for the many sacrifices she has so unselfishly made for my happiness. iii TABLE OF CONTENTS Page LIST OF ILLUSTRATIONS vi LIST OF TABLES viii ABSTACT ix 1. INTRODUCTION 1 Physical-Chemical Properties of Arsenic 1 Applications of Arsenic 1 Arsenic Exposures 2 Toxicity 7 Carcinogenisis . 13 Interactions with Other Metals 17 Teratogenicity 17 Genetic Effects 18 Absorption, Distribution, and Metabolism of Arsenic ... 20 Arsenic Metabolism in the Rabbit 25 Arsenic Metabolism in the Marmoset Monkey 27 Principles of Chelation 28 Chelators 30 BAL 30 DMPS 32 DMSA 35 DMPA 36 WR2721 38 2. MATERIALS AND METHODS 39 Rabbits 39 Reagents 39 Dosing Solutions 41 Instrumentation 44 Animal Studies 48 Part 1 ( As Tracer Studies) 48 Part 2 (Arsenic Content of Brain Tissue) 50 Part 3 (Effect of Arsenic Valence State) 50 Part 4 (Atonic Absorption Studies) 51 Statistics 52 iv V TABLE OF CONTENTS—Continued Page 3. RESULTS 53 Part 1 (^ As Tracer Studies) 53 Part 2 (Arsenic Content of Brain Tissue) 61 Part 3 (Effect of Arsenic Valence State) 6B Part 4 (Atomic Absorption Studies) 71 4. DISCUSSION AND CONCLUSION 75 REFERENCES 84 LIST OF ILLUSTRATIONS Figure Page IA. Arsenical compounds (R-As=0) inhibit the fontation of lipoate from dihydrolipoate (Schoolmeester and White 1980) 9 IB. Arsenic depletes lipoate, blocking acety-CoA formation and thus interfering with the Krebs cycle (Schoolmeester and White 1980) 9 2. Prevalence of skin cancer with respect to age and arsenic concentration in well water (Tseng et al. 1968) 16 3. Sites of teratogenic effects of 4 different elements on embryonic development in the golden hamster (Ferm 1972) 19 4. TLC separation and purity check of sodium arsenite and sodium arsenate 42 5. Stability check of As (+3) dosing solution 43 6. Spectrum plot of arsenic-74 produced by LKB 1282 gamria counter 45 7. Spectrum plot of arsenic-73 obtained from LKB 1282 gairma counter. 47 8. Typical recorder tracing from atomic absorption analysis 49 9. Liver arsenic-74 concentration of rab^jts 24 hours after dosing with sodium arsenite- As and 23 hours post chelator administration 54 10. Concentration of arsenic-74 in the kit^eys of rabbits receiving sodium arsenite- As and the various chelators 55 11. Percent arsenic-74 dose remaining in the lungs after chelation therapy 56 vi vii LIST OF ILLUSTRATIOJS—Continued Figure Page 12. Arsenic concentration in brain tissue following administration of various chelating agents 59 13. Percent arsenic dose excreted in the feces 24 hours after arsenic administration 60 14. Urinary arsenic-74 excretion 24 hours post arsenic dose 62 15A. Brain arsenic concentration of rabbits administered sodium arsenite and followed by saline, BAL, or DMPS 67 15B. Brain arsenic concentration of rabbits given sodium arsenite followed by fractionated doses of saline, BAL, or a peanut oil/benzyl benzoate solution 67 LIST OF TABLES Table Page I. Medicinal uses of arsenic compounds (Woolson 1975).... 3 II. Occupations with potential arsenic exposure (Costa 1980) 4 III. Estimated dietary intakes of heavy metals by food class (Qehme 1978) 6 IV. Enzymes inhibited by arsenic (Carnow 1976) 8 V. Signs and symptoms of arsenic intoxication in animals and man (Carnow 1975) 12 VI. Arsenic concentration and prevalence of warts and pigmentation (Perry et al. 1948) 16 VII. Structures of the Chelators used in this study 31 VIII. Comparison of seme of the information available about DMPS and DMPA (Aposhian 1982) 37 IX. The effect of various chelators on the concentration of arsenic-74 in tissue 58 X. Probability values for the means of various chelators tested accordind to tissue type 63 XI. Comparison of brain weight to body weight ratios for control and test animals receiving BAL 69 XII. Effect of dl-DMSA on the mobilization of arsenic-74 (+5) in the presence of excess sodium arsenite (+3) or sodium arsenate (+5) 70 XIII. Effects of arsenic oxidation state and BAL therapy on arsenic concentration in brain tissue 72 XIV. Effect of BAL therapy and arsenic oxidation state on the urinary excretion of arsenic in rabbits .... 74 viii ABSTRACT The purpose of this work was to assess the effectiveness of several thiolic carpounds and their isaners in increasing the excretion and tissue mobilization of arsenic in male New Zealand white rabbits.
Recommended publications
  • Industry Compliance Programme
    Global Chemical Industry Compliance Programme GC-ICP Chemical Weapons Convention December 2006 Version 1.0 GLOBAL CHEMICAL INDUSTRY COMPLIANCE PROGRAMME FOR IMPLEMENTING THE CHEMICAL WEAPONS CONVENTION The purpose of the handbook is to provide guidance to chemical facilities, traders and trading companies in developing a Global Chemical Industry Compliance Programme (GC-ICP) to comply with the Chemical Weapons Convention (CWC). The GC-ICP focuses first on determining if there is a reporting requirement to your National Authority and second on collecting the relevant support data used to complete the required reports. The GC-ICP is designed to provide a methodology to comply with the CWC and establish systems that facilitate and demonstrate such compliance. Each facility/company should also ensure that it follows its country’s CWC specific laws, regulations and reporting requirements. • Sections 2, 3, and 4 guide you through the process of determining if chemicals at your facility/ company should be reported to your National Authority for compliance with the CWC. • Section 5 provides recommended guidance on information that you may use to determine your reporting requirements under the CWC and administrative tools that your facility/company may use to ensure compliance with the CWC. • Section 6 provides a glossary of terms and associated acronyms. • Section 7 provides a listing of all National Authorities by country. CWC Global Chemical Industry Compliance Programme 1 TABLE OF CONTENTS Section 1 Overview What is the Chemical Weapons Convention?
    [Show full text]
  • Responding to a Chemical Warfare Agent Incident: from Sampling and Analysis to Decontamination and Waste Management Stuart Willi
    Responding to a Chemical Warfare Agent Incident: from sampling and analysis to decontamination and waste management Stuart Willison & Lukas Oudejans U. S. EPA National Homeland Security Research Center 1 Outline • Homeland Security Relevance to Chemical (Warfare Agent) Incidents and Incident Response Cycle • Identification of Gaps/Needs: PARTNER Process and Stakeholder Priorities • Current High Stakeholder Priorities • Research Efforts to meet these Needs/Gaps Selected Analytical Methods (SAM) Document CWA Method Development and Wipe Efficiency Studies on Surfaces Fate and Transport of CWAs Natural Attenuation of VX Decontamination of Vesicant/Blister CWAs HD, L, HL Analytical Method Development: Lewisite; EA 2192 Best Practices Document for Waste Media from Remediation Activities • Summary 2 Response to Contamination Events Since 9/11, multiple chemical/biotoxin contamination events have occurred in the United States and worldwide: • Several ricin incidents (2002-2014) • Deepwater Horizon oil spill (April 2010) • Kalamazoo River oil spill (July 2010) • CWA sulfur mustard clam shells (2010) • CWA chemical attacks (Syria, Middle East) (March-August 2013 and April 2014-current) • Elk River chemical spill in West Virginia (January 2014) • Toxic algae blooms in Toledo, OH (August 2014) • Arsenic-contaminated soil in Kentucky potentially containing CWA Lewisite (March 2015) • (Organophosphate-) Pesticide over- or misuse across USA in relation to bed bug epidemic (current) 3 Response Cycle Contaminant Release Reduce Vulnerabilities Lessons
    [Show full text]
  • Supplement to All Hazards Receipt Facility (AHRF) Screening Protocol
    EPA/600/R-10/155 December 2010 Supplement to All Hazards Receipt Facility (AHRF) Screening Protocol SCIENCE Office of Research and Development National Homeland Security Research Center Supplement to All Hazards Receipt Facility (AHRF) Screening Protocol December 2010 Office of Research and Development National Homeland Security Research Center Acknowledgments This document is intended to be supplementary to the U.S. Environmental Protection Agency (EPA) and U.S. Department of Homeland Security (DHS) September 2008 All Hazards Receipt Facility Protocol (AHRF Protocol), and attempts to address considerations raised by stakeholders since publication of the protocol. Development of this document was funded by the U.S. Environmental Protection Agency (EPA) National Homeland Security Research Center (NHSRC), and includes information provided by EPA Regions 1, 6, and 10; EPA Office of Radiation and Indoor Air (ORIA), the Association of Public Health Laboratories (APHL): State Public Health Laboratories of Connecticut, Delaware, Massachusetts, Minnesota, New Jersey, New York, and Virginia; and New York City; and the Canadian Defence Research and Development Laboratory. This document was prepared by CSC under Contract EP-W-06- 046. Disclaimer This document is intended to be supplementary to the guidance provided in the U.S. Environmental Protection Agency (EPA) and U.S. Department of Homeland Security (DHS) September 2008 All Hazards Receipt Facility Protocol (AHRF Protocol), and attempts to address considerations raised by stakeholders since publication of the protocol. This supplement assumes that: • The September 2008 AHRF Protocol was developed and provided as a guide; implementation of the protocol and the screening equipment included in the protocol may vary among locations, depending on the goals and capabilities of the laboratory to which the facility is attached.
    [Show full text]
  • Selected Analytical Methods for Environmental Remediation and Recovery (SAM) 2017
    EPA/600/R-17/356 | September 2017 www.epa.gov/homeland-security-research Selected Analytical Methods for Environmental Remediation and Recovery (SAM) 2017 Office of Research and Development Homeland Security Research Program This page left intentionally blank EPA/600/R-17/356 | September 2017 Selected Analytical Methods for Environmental Remediation and Recovery (SAM) 2017 UNITED STATES ENVIRONMENTAL PROTECTION AGENCY Cincinnati, OH 45268 Office of Research and Development Homeland Security Research Program Disclaimer Disclaimer The U.S. Environmental Protection Agency (EPA) through its Office of Research and Development funded and managed the research described here under Contract EP-C-15-012 to CSRA Inc. This document is undergoing review and has not been approved for publication. The contents reflect the views of the contributors and technical work groups and do not necessarily reflect the views of the Agency. Mention of trade names or commercial products in this document or in the methods referenced in this document does not constitute endorsement or recommendation for use. Questions concerning this document or its application should be addressed to: Romy Campisano National Homeland Security Research Center Office of Research and Development (NG16) U.S. Environmental Protection Agency 26 West Martin Luther King Drive Cincinnati, OH 45268 (513) 569-7016 [email protected] Kathy Hall National Homeland Security Research Center Office of Research and Development (NG16) U.S. Environmental Protection Agency 26 West Martin Luther King
    [Show full text]
  • UAH Chemical Hygiene Plan
    UAH CHEMICAL HYGIENE Effective Date: Feb. 2014 PLAN The Campus Chemical Hygiene Plan (Campus CHP) was developed to ensure the safety of laboratory employees and maintain compliance with the OSHA Laboratory Standard. In addition to OSHA regulations, this document also presents key information on the practices and procedures that must be implemented to maintain compliance with other state, federal, and local regulations required for the use and storage of hazardous chemicals. Prepared by: The Office of Environmental Health & Safety Contents 1. Introduction .............................................................................................................................. 1 1.1 Purpose .................................................................................................................................................. 1 1.2 Background on Regulatory Compliance .................................................................................... 1 1.3 Chemical Hygiene Plan Overview ................................................................................................. 2 1.4 Scope and Applicability .................................................................................................................... 3 1.5 Implementation of the Plan ............................................................................................................ 4 1.6 Availability of the Plan ..................................................................................................................... 4 1.7 Annual
    [Show full text]
  • Things to Be Done
    DRAFT MAY 2003 ANNEX 1: CHEMICAL AGENTS 1. Introduction The large-scale use of toxic chemicals as weapons first became possible during the First World War (1914–1918) thanks to the growth of the chemical industry. More than 110 000 tonnes were disseminated over the battlefields, the greater part on the western front. Initially, the chemicals were used, not to cause casualties in the sense of putting enemy combatants out of action, but rather to harass. Though the sensory irritants used were powerful enough to disable those who were exposed to them, they served mainly to drive enemy combatants out of the trenches or other cover that protected them from conventional fire, or to disrupt enemy artillery or supplies. About 10% of the total tonnage of chemical warfare agents used during the war were chemicals of this type, namely lacrimators (tear gases), sternutators and vomiting agents. However, use of more lethal chemicals soon followed the introduction of disabling chemicals. In all, chemical agents caused some 1.3 million casualties, including 90 000 deaths. During the First World War, almost every known noxious chemical was screened for its potential as a weapon, and this process was repeated during the Second World War (1939–1945), when substantial stocks of chemical weapons were accumulated, although rarely used in military operations. Between the two world wars, a high proportion of all the new compounds that had been synthesized, or isolated from natural materials, were examined to determine their utility as lethal or disabling chemical weapons. After 1945, these systematic surveys continued, together with a search for novel agents based on advances in biochemistry, toxicology and pharmacology.
    [Show full text]
  • Provisional Peer-Reviewed Toxicity Values for Lewisite (Casrn 541-25-3)
    EPA/690/R-15/009F l Final 9-30-2015 Provisional Peer-Reviewed Toxicity Values for Lewisite (CASRN 541-25-3) Superfund Health Risk Technical Support Center National Center for Environmental Assessment Office of Research and Development U.S. Environmental Protection Agency Cincinnati, OH 45268 AUTHORS, CONTRIBUTORS, AND REVIEWERS CHEMICAL MANAGER Dan D. Petersen, PhD, DABT National Center for Environmental Assessment, Cincinnati, OH DRAFT DOCUMENT PREPARED BY SRC, Inc. 7502 Round Pond Road North Syracuse, NY 13212 PRIMARY INTERNAL REVIEWERS Jeffery Swartout, PhD, DABT National Center for Environmental Assessment, Cincinnati, OH This document was externally peer reviewed under contract to: Eastern Research Group, Inc. 110 Hartwell Avenue Lexington, MA 02421 3136 Questions regarding the contents of this document may be directed to the U.S. EPA Office of Research and Development’s National Center for Environmental Assessment, Superfund Health Risk Technical Support Center (513-569-7300). ii Lewisite TABLE OF CONTENTS COMMONLY USED ABBREVIATIONS AND ACRONYMS .................................................. iv BACKGROUND .............................................................................................................................1 DISCLAIMERS ...............................................................................................................................1 QUESTIONS REGARDING PPRTVs ............................................................................................1 INTRODUCTION ...........................................................................................................................2
    [Show full text]
  • Lewisite (L) Team (NRT) Quick Reference Guides (Qrgs) for Chemical Warfare Agents
    NRT Quick Reference Guide: For references, please see Key References Cited/Used in National Response Lewisite (L) Team (NRT) Quick Reference Guides (QRGs) for Chemical Warfare Agents. [July 2015 Update] QRGs are intended for Federal OSC/RPMs. Agent Classification: Schedule 1 Chemical Warfare Blister (Vesicant) Agent; CAS: 541-25-3; Formula: C2H2AsCl3; Molecular Weight: 207.35 g/mol. Description: Lewisite is referred to as L-1 and is oily, colorless and odorless. When impure, it is a yellow brown through violet black liquid with a strong penetrating geranium odor. The manufacturing process affects physical properties, appearance, persistence, and analytical detection limits. Common impurities include two related compounds, lewisite 2 (L-2) and lewisite 3 (L-3). This QRG is based on L-1 but includes aspects of L-2 and L-3, and will use “L” as the collective abbreviation. L is a blister (vesicant) agent that produces immediate burning pain with blistering starting within a few hours. L is less volatile than Sarin (GB); it is much more volatile than persistent agents VX or HD. Environmental breakdown products of L are easily formed and include highly toxic arsenic (III) compounds, such as arsenites, lewisite oxide, and 2-chlorovinyl arsenous acid (CVAA); some cause similar blistering as L. Decontamination by-products of L include arsenic (V) compounds, which are generally less toxic than arsenic (III) compounds, but may be considered hazardous. Persistence: L is considered a “low to moderate persistent” chemical warfare agent. Vapor: minutes to hours; liquid: hours to days. Persistence will depend upon amount and purity of the agent, method of release, environmental conditions, and the types of surfaces and materials impacted.
    [Show full text]
  • CODE of COLORADO REGULATIONS 6 CCR 1007-3 Part 8 Hazardous Materials and Waste Management Division
    DEPARTMENT OF PUBLIC HEALTH AND ENVIRONMENT Solid and Hazardous Waste Commission/Hazardous Materials and Waste Management Division HAZARDOUS WASTE - STATEMENTS OF BASIS AND PURPOSE 6 CCR 1007-3 Part 8 [Editor’s Notes follow the text of the rules at the end of this CCR Document.] _________________________________________________________________________ Statement of Basis and Purpose – Rule-making Hearing of May 18, 1993 Hazardous Waste Management System; Identification and Listing of Hazardous Waste; Wood Preserving 8.1 Basis and Purpose. These amendments to 6 CCR 1007-3, sections 100.41(b), 261.4(a), 262.34, 261.35(b), 264.190, 264.570, 264.571264.572, 264.573264.574, 264.575, 265.190, 265.440, 265,441, 265.442, 265.443, 265.444 and 265.445 an promulgated pursuant to the authority granted the Hazardous Waste Commission in section 25-15-302(2), C.R.S. Effective June 6,1991 the Environmental Protection Agency (“EPA”) adopted amendments to rules under the Resource Conservation and Recovery Act listing as hazardous three categories of wastes from wood preserving operations that use chlorophenolic, creosote, and/or inorganic (arsenical and chromium) preservatives. The listings included wastewaters, process residuals, preservative drippage, and spent preservatives from wood preserving processes at facilities that use or have previously used chlorophenolic formulations, facilities that use creosote formulations, and facilities that use inorganic preservatives containing arsenic or chromium. The rules also included permitting and interim status standards for drip pads used to assist in the collection of treated wood drippage. The promulgation of these rules provide state equivalency with the rules of the EPA and assure authorization of the state hazardous waste program.
    [Show full text]
  • The Role of the Clinical Laboratory in Managing Chemical Or Biological Terrorism
    Clinical Chemistry 46:12 1883–1893 (2000) Review The Role of the Clinical Laboratory in Managing Chemical or Biological Terrorism Saeed A. Jortani,1 James W. Snyder,1 and Roland Valdes, Jr.1,2* Background: Domestic and international acts of terror- to respond to such attacks. Accurate assessment of ism using chemicals and pathogens as weapons have resources in clinical laboratories is important because it recently attracted much attention because of several will provide local authorities with an alternative re- hoaxes and real incidents. Clinical laboratories, espe- source for immediate diagnostic analysis. It is, therefore, cially those affiliated with major trauma centers, should recommended that clinical laboratories identify their be prepared to respond rapidly by providing diagnostic current resources and the extent of support they can tests for the detection and identification of specific provide, and inform the authorities of their state of agents, so that specific therapy and victim management readiness. can be initiated in a timely manner. As first-line re- © 2000 American Association for Clinical Chemistry sponders, clinical laboratory personnel should become familiar with the various chemical or biological agents Release of chemical and biological warfare agents threat- and be active participants in their local defense pro- ens civilian populations throughout the world. Potential grams. sources of exposure include accidental release from mili- Approach: We review the selected agents previously tary factories and stockpiles,
    [Show full text]
  • The Three Schedules
    Scheduled Chemicals under the Chemical Weapons Convention (CWC) Schedule 1 Schedule 2 Schedule 3 Guidelines for Schedule 1 Guidelines for Schedule 2 Guidelines for Schedule 3 The following criteria shall be taken into account in considering whether a toxic The following criteria shall be taken into account in considering whether a toxic The following criteria shall be taken into account in considering whether a toxic chemical or precursor should be included in Schedule 1: chemical not listed in Schedule 1 or a precursor to a Schedule 1 chemical or to a chemical or precursor, not listed in other Schedules, should be included in (a) It has been developed, produced, stockpiled or used as a chemical weapon as chemical listed in Schedule 2, part A, should be included in Schedule 2: Schedule 3: defined in Article II; (a) It poses a significant risk to the object and purpose of this Convention because (a) It has been produced, stockpiled or used as a chemical weapon; (b) It poses otherwise a high risk to the object and purpose of this Convention by it possesses such lethal or incapacitating toxicity as well as other properties (b) It poses otherwise a risk to the object and purpose of this Convention because it virtue of its high potential for use in activities prohibited under this that could enable it to be used as a chemical weapon; possesses such lethal or incapacitating toxicity as well as other properties that Convention because one or more of the following conditions are met: (b) It may be used as a precursor in one of the chemical reactions
    [Show full text]
  • Federal Register/Vol. 64, No. 95/Tuesday, May 18, 1999/Rules
    27138 Federal Register / Vol. 64, No. 95 / Tuesday, May 18, 1999 / Rules and Regulations DEPARTMENT OF COMMERCE ADDRESSES: Written comments should families of chemicals. The United States be sent to Nancy Crowe, Regulatory is a participant in the Australia Group Bureau of Export Administration Policy Division, Bureau of Export (AG), a 30-nation multilateral chemical Administration, Room 2705, 14th Street and biological weapons non- 15 CFR Parts 734, 736, 738, 740, 742, and Pennsylvania Ave., NW, proliferation regime. All AG 745, 748, 758, 772 and 774 Washington, DC 20230. participants have national export [Docket No. 990416098±9098±01] FOR FURTHER INFORMATION CONTACT: controls on 54 precursor chemicals, Nancy Crowe, Regulatory Policy some of which are listed on the CWC RIN 0694±AB67 Division, Bureau of Export Schedules, and on chemical-related Implementation of the Chemical Administration, at (202) 482±2440. production equipment. Two Schedule 1 Weapons Convention; Revisions to the SUPPLEMENTARY INFORMATION: toxins, ricin and saxitoxin, are subject to Export Administration Regulations the EAR, are listed in Export Control Background Classification Number (ECCN) 1C351 on AGENCY: Bureau of Export As a party to the Convention on the the Commerce Control List (CCL), and Administration, Commerce. Prohibition of the Development, currently require a license for chemical ACTION: Interim rule. Production, Stockpiling, and Use of and biological (CB) non-proliferation Chemical Weapons and on Their reasons for export to all destinations SUMMARY: On
    [Show full text]